Movano Inc.MOVEEarnings & Financial Report
Movano Inc. is a U.S.-headquartered health technology company specializing in developing miniaturized, non-invasive wearable medical devices. Its core offerings include continuous glucose monitors, blood pressure tracking wearables, and integrated health data platforms, serving individual consumers and healthcare provider segments to deliver accessible chronic condition management solutions.
MOVE Q4 FY2025 Key Financial Metrics
Revenue
$44.0K
Gross Profit
N/A
Operating Profit
N/A
Net Profit
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
-60.4%
Movano Inc. Q4 FY2025 Financial Summary
Movano Inc. reported revenue of $44.0K (down 60.4% YoY) for Q4 FY2025, with a net profit of N/A (down 26.8% YoY) (N/A margin).
Key Financial Metrics
| Total Revenue | $44.0K |
|---|---|
| Net Profit | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 FY2025 |
Movano Inc. Annual Revenue by Year
Movano Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $433.0K).
Movano Inc. Quarterly Revenue & Net Profit History
Movano Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $44.0K | -60.4% | N/A | N/A |
| Q3 FY2025 | $80.0K | +60.0% | $-4.0M | -5036.3% |
| Q2 FY2025 | $103.0K | — | $-3.2M | -3131.1% |
| Q1 FY2025 | $206.0K | -75.8% | $-5.2M | -2513.6% |
| Q4 FY2024 | $111.0K | — | $-4.6M | -4158.6% |
| Q3 FY2024 | $50.0K | — | $-7.2M | -14402.0% |
| Q2 FY2024 | $0 | — | $-6.2M | N/A |
| Q1 FY2024 | $852.0K | +696.3% | $-5.7M | -671.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $852000 | $0 | $50000 | $111000 | $206000 | $103000 | $80000 | $44000 |
| YoY Growth | 696.3% | N/A | N/A | N/A | -75.8% | N/A | 60.0% | -60.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.1M | $20.8M | $15.1M | $11.3M | $7.8M | $5.7M | $5.6M | $5.6M |
| Liabilities | $6.6M | $4.0M | $4.8M | $4.0M | $4.5M | $4.0M | $7.3M | $9.1M |
| Equity | $-1.5M | $16.8M | $10.3M | $7.4M | $3.2M | $1.6M | $-1.7M | $-3.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-4.1M | $-8.2M | $-5.7M | $-4.6M | $-4.3M | $-3.1M | $-1.6M | $-11.3M |